Genomtec SA
4 products found

Genomtec SA products

Genomtec - Saliva Sample Collector

Saliva Sample Collector Device can be used for the collection, storage and transportation of native saliva sample for clinical diagnostic purposes and does not contain any nucleic acid stabilizing solution. It is DNaze / RNaze and pyrogen free and sterilized by radiation. The product is compatible for saliva-based testing using Genomtec® SARS-CoV-2 EvaGreen® Direct-RT-LAMP CE-IVD Kit (cat. no.: GA00C).

Genomtec - Mobile Platform for Genetic Diagnostics

Genomtec ID is a flagship technological solution currently under development, which will offer patients ultrafast mobile genetic diagnosis utilizing SNAAT®. The Genomtec ID platform makes it possible to run a diagnostic process at point of care, i.e., public clinics, consulting rooms, hospital, pharmacies and emergency wards, without the need of complicated and time-consuming handling by skilled personnel in the laboratory.

Genomtec - SARS-Cov-2 EvaGreen Direct-RT-LAMP CE-IVD Kit

Genomtec® SARS-CoV-2 EvaGreen® Direct-RT-LAMP CE-IVD Kit is Real-Time Reverse Transcription Loop-Mediated Isothermal Amplification (RT-LAMP) test for qualitative detection of nucleic acid from two genes of SARS-CoV-2 virus with a streamlined biological sample processing that is CE-IVD labelled for diagnostic use in the EU.* It features rapid RNA isolates preparation in conjugation with the simultaneous RNA transcription and cDNA amplification utilizing standard Real-Time PCR instrument workflow (detection in FAM channel), with sample to result time in approx. 50 minutes of which amplification stage takes only 40 minutes.

Genomtec - Tumor / Immunogenetics

Currently, the Genomtec Tumor project is in its early phase, adopting SNAAT®-based solutions that could be used to quickly identify neoplastic mutations or mutations that are of prognostic value in neoplastic disease, as part of companion diagnostics (CDx) solution. The SNAAT® method shall be adapted for near-patient testing of neoplastic mutations and will allow quick implementation of personalized treatment. If combined with protein markers, it may be possible to create a diagnostic platform for screening tests and/or highly specific antigen identification in immunogenetic testing.